Concepedia

Thomas Daubon

TD

Statistics

Publications

34

Citations

2K

H-Index

24

Active since

2006

Affiliations

Inserm(Current)

Université de Bordeaux

Centre National de la Recherche Scientifique

University of Bergen

Haukeland University Hospital

Thomas Daubon is an author at Inserm specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2006–2024

34

Publications

34

Deciphering the complex role of thrombospondin-1 in glioblastoma development

Thomas Daubon, Céline Léon, Kim Clarke et al. · Nature Communications · 2019 · 237 citations · Full text

, , +17

GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity

Dionysios C. Watson, Simon Storevik, Shannon Sherwin Moreino et al. · Nature Cancer · 2023 · 215 citations · Full text

, , +17

<i>Drosophila melanogaster</i> γ-TuRC is dispensable for targeting γ-tubulin to the centrosome and microtubule nucleation

Christel Vérollet, Nathalie Colombié, Thomas Daubon et al. · The Journal of Cell Biology · 2006 · 115 citations · Full text

, , +14

SLIT2/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia

Luiz Henrique Geraldo, Yunling Xu, Laurent Jacob et al. · Journal of Clinical Investigation · 2021 · 114 citations · Full text

, , +17

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation

Eskil Eskilsson, Krishna M. Talasila, Stian Knappskog et al. · Neuro-Oncology · 2016 · 113 citations · Full text

, , +17

1–5 of 34